GLP-1 Weight-Loss Drugs Create New Demand Reality for U.S. Potato Growers

The rapid adoption of GLP‑1 weight‑loss drugs like Ozempic and Wegovy is reducing overall food consumption, creating new demand challenges for U.S. potato growers. Jamey Higham, president and CEO of the Idaho Potato Commission, says the shift could deepen potato oversupply and force growers to better align production and marketing with changing eating habits.